Email Updates

You are here

Home»Media

AVAC in the News

  • COVID-19 Has Killed More People in the US Than HIV/AIDS Did in 40 years

    COVID-19 has now killed about 730,000 people in the US, making it the deadliest pandemic in the nation's history, with more lives claimed than by HIV/AIDS. The tally comes as the US marks four decades since HIV — the virus that can cause AIDS — was first detected in the country, and some are now looking at the two vastly different diseases and seeing parallels. The US government's initial approach to both HIV/AIDS and COVID was denial and indifference.

    October 21, 2021
    General
    The National News

  • Initiatives To Accelerate the Long and Difficult Search for an HIV Vaccine

    It is paradoxical that the speed in obtaining vaccines against COVID-19 is due, in large part, to the enormous advantage provided by research on HIV and its key technologies and that, however, we still continue without an immunization against the virus AIDS. To move forward, we need increased funding and consistent commitment from the industry.

    October 14, 2021
    HIV Vaccine
    Agencia SINC

  • John Nkengasong, Ph.D., Is Biden’s Pick to Fill the Long-Empty Role of US Global AIDS Czar

    In June, we reported that PEPFAR, the $7 billion US global-AIDS relief program started by President George W. Bush in 2003, had been leaderless for more than a year. This left global AIDS advocates worried that the program was losing momentum and focus, especially amid the new global pandemic of COVID-19.

    October 12, 2021
    General
    TheBody

  • First COVID, Now HIV. Moderna and San Diego Researchers Race To Make a Vaccine

    Researchers plan to use a series of shots to teach people’s immune systems to produce powerful antibody responses against the virus. But while the strategy is raising hopes and is built on years of research, there’s no guarantee it succeeds.

    October 7, 2021
    HIV Vaccine
    San Diego Union-Tribune

  • Nkengasong Eyes Big Job at PEPFAR, but Africa CDC May Miss Him

    Just how will the Africa Centres for Disease Control (Africa CDC) run after its famed leader John Nkengasong leaves? The answer may not be apparent, but the Cameroonian-American virologist, who has recently become the face of Africa’s campaign for vaccine equity, could be departing the organisation soon.

    September 28, 2021
    General
    The East African

  • Public Health Leader Will Be First African to Helm PEPFAR

    For the first time in its 18-year history, the President’s Emergency Plan For AIDS Relief (PEPFAR) will be headed by an African public health leader, according to a report in the New York Times. President Joe Biden plans to appoint John Nkengasong, MD, as head of the federal agency that serves people living with HIV worldwide.

    September 27, 2021
    General
    POZ

  • Nkengasong’s Bittersweet Departure From Africa CDC

    United States President Joe Biden is reportedly nominating Dr. John Nkengasong, director of the Africa Centres for Disease Control and Prevention, to head the US President’s Emergency Plan for AIDS Relief, a $7 billion operation. The US government initiative has been without a leader since February. The Cameroonian virologist would be the first person from the African continent to head the program.

    September 22, 2021
    General
    Devex

  • The Race To Vaccinate: Why Africa Is Struggling To Get COVID Jabs

    Vaccines were promoted as a silver bullet to end the pandemic, the path to finally beating COVID-19. But in Africa, they remain scarce, with access hampered by hoarding, export bans and empty promises. Nearly six billion vaccine doses have been administered globally, but only two percent of those have been in Africa.

    September 21, 2021
    General
    France 24

  • John Nkengasong, of the Africa CDC, Will Lead PEPFAR

    The Biden administration plans to nominate John Nkengasong, a virologist and director of the Africa Centers for Disease Control and Prevention, to lead the President’s Emergency Plan for AIDS Relief, according to several sources familiar with the matter.

    September 21, 2021
    General
    New York Times

  • Integration of HIV and Sexual and Reproductive Health in the Era of Anti-Retroviral-Based Prevention: Findings From Assessments in Kenya, Malawi and Zimbabwe

    As new HIV prevention products are introduced, demand for integrated HIV/SRH services is likely to grow. Investing in HIV/SRH integration can help to ensure sustainable, government-led responses to the HIV epidemic, streamline service delivery and improve the health outcomes and lives of AGYW.

    September 15, 2021
    General, PrEP
    Gates Open Research

Pages